All News #Library
Others
Thryv Therapeutics - 2023 Year End Report
19 Dec 2023 //
PR NEWSWIRE
Thryv Announces Progress Across all Programs within its SGK1 Inhibitor Portfolio
06 Jun 2023 //
PR NEWSWIRE
Thryv Therapeutics to Participate in Piper Sandler Annual Healthcare Conference
17 Nov 2022 //
PRNEWSWIRE

Market Place
Sourcing Support